About this trial
A prospective multicenter randomized controlled trial was conducted to evaluate the diagnostic efficacy and safety of NCLE-NB-Rebus-guided peripheral pulmonary nodule biopsy, and to compare the diagnostic efficacy and safety of biopsy forceps biopsy and needle aspiration biopsy in peripheral pulmonary nodule biopsy guided by nCLE-NB-rEBUS.
Eligibility criteria
Qualifiers
Patients with peripheral pulmonary nodules suspected of lung cancer by CT examination
Patients who intend to undergo a bronchoscopic lung biopsy to determine benign or malignant pulmonary nodules;
Age ≥18 years
Sign informed consent.
Disqualifiers
There is an uncorrectable coagulation disorder or anticoagulation therapy that cannot be stopped before surgery;
Tumors can be seen in the bronchus
Hemodynamic instability;
Refractory hypoxemia;
Trial design
Treatments tested in this trial
- Navigation bronchoscopy combined with radial endobronchial ultrasound guided pulmonary nodule biopsy under needle-based confocal laser endomicroscopy.